v3 Template
C

CUTISS

Biotechnology / Healthcare ~2K employees
Founded
--
Employees (Est.)
~2K
77 leaders known
Total Funding
$61.6M
Funding Rounds
1
Last Funding
2025-09-10

About CUTISS

CUTISS is a late-stage clinical TechBio company focused on developing skin tissue therapeutics and bioengineering. They aim to transform skin surgery with their first-in-class personalized tissue therapy, denovoSkin™, which enables automated, on-demand production of living skin at scale for patients requiring skin surgery, from massive burns to reconstructive and aesthetic applications.

Products & Services

denovoSkin™:A personalized tissue therapy for skin surgery, offering long-term safety and efficacy compared to standard care. It is used for massive burns, reconstructive, and aesthetic applications, manufactured in-house at a GMP facility in Zurich, Switzerland.
Automation Platform:A first-in-class, patented, fully-closed, end-to-end system for scalable production of personalized tissue therapy. It supports decentralized production, cost-effective scale-up, and high ROI, with applications in regenerative medicine, space health research, and industrial bioengineered tissues.

Specialties

Skin Tissue Therapeutics Bioengineering Regenerative Medicine Automated Tissue Production Space Health Research

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series C
T: -
FT: Series C 		A: 61600000
MR: -
FA: CHF 56M
FAN: 61600000 		D: 2025-09-10
FD: 2025-09-10 		1 investors
Series C Latest
2025-09-10
$61.6M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

D

Daniela Marino

CEO / Co-Founder / Member of the Board of Directors

LinkedIn (Pro only)
V

Vincent Ronfard

Chief Innovation Officer

LinkedIn (Pro only)
K

Kathi Mujynya Ludunge

Chief Operating Officer

LinkedIn (Pro only)
M

Martin Meuli

President of the Board of Directors and Co-Founder

E

Ernst Reichmann

Co-Founder and Member of the Board of Directors

G

Giammaria Giuliani

Member of the Board of Directors

View 74 more team members with Pro

Unlock Full Team Directory

Recent News

CUTISS Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Healthcare
Company Size
~2K employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro